The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin

NeuroReport

Volumn 10, Issue 6, 1999, Pages 1183-1187

  Tang Christensen, Mads ^a   Holst, Jens J ^b   Hartmann, Bolette ^b   Vrang, Niels ^b  

^a NOVO NORDISK A S   (Denmark)

^b NONE

Author keywords

Arcuate nucleus; Corticosterone; Food intake; Ingestive behaviour; Insulin; MSG treatment

Indexed keywords

CORTICOSTERONE; LEPTIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; ENERGY EXPENDITURE; FACILITATION; FOOD INTAKE; GENETIC TRANSCRIPTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR GENE;

EID: 0033606061     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199904260-00005     Document Type: Article

References (29)

1. 1. Friedman JM and Halass JL. Nature 395, 763-770 (1998).
2. 2. Sinha MK, Ohannesian JP, Heiman ML et al. J Clin Invest 97, 1344-1347 (1996).
3. 3. Saladin R, De Vos P, Guerre-Millo M et al. Nature 377, 527-529 (1995).
4. 4. Slieker LJ, Sloop KW, Surface PL et al. J Biol Chem 271, 5301-5304(1996).
5. 5. Weigle DS, Duell PB, Connor WE et al. J Clin Endocrinol Metab 82, 561-565 (1997).
6. 6. Ahima RS, Prabakaran D, Mantzoros C et al. Nature 382, 251-252 (1996).
7. 7. Tang-Christensen M, Havel P, Jacobs RR et al. J Clin Endocrinol Metab 84(2), 711-717 (1999).
8. 8. Seeley RJ, van Dijk G, Campfield LA et al. Horm Metab Res 28, 664-668 (1996).
9. 9. Banks WA, Kastin AJ, Huang W et al. Peptides 17, 305-11 (1996).
10. 10. Chen H, Charlat O, Tartaglia LA et al. Cell 64, 491-495 (1996).
11. 11. Lee GH, Proenca R, Montëz JM et al. Nature 379, 632-635 (1996).
12. 12. Schwartz MW, Seeley RJ, Campfield LA et al. J Clin Invest 98, 1101-1106 (1996).
13. 13. Elmquist JK, Ahima RS, Maratos FE et al. Endocrinology 138, 839-842 (1997).
14. 14. Hekansson M-L, Brown H, Ghilardi N et al. J Neurosci 18, 559-572(1998).
15. 15. Mercer JG, Hoggard N, Williams LM et al. J Neuroendocrinol 8, 733-735 (1996).
16. 16. Stephens TW, Basinski M, Bristow P et al. Nature 377, 530-533 (1995).
17. 17. Mizuno TM, Kleopoulos SP, Bergen HT et al. Diabetes 47, 294-297 (1998).
18. 18. Kristensen P, Judge M, Thim L et al. Nature 393, 72-76 (1997).
19. 19. Dawson R, Pelleymounter MA, Millard WJ et al. Am J Physiol 273, E202-E206 (1997).
20. 20. Olney JW, Schainker B and V.R. Chemical lesioning of the hypothalamus as a means of studying neuroendocrine function. In: Sachar EJ, ed., Hormones, Behavior, and Psychopathology. New York: Raven Press, 1976: 153-158.
21. 21. Meister B, Ceccatelli S, Hškfelt T et al. Exp Brain Res 76, 343-368 (1989).
22. 22. Brand CL, Jorgensen PN, Knigge U et al. Am J Physiol 269, E469-E477 (1995).
23. 23. Tang-Christensen M. Vrang N and Larsen PJ. Diabetes 47, 530-537 (1998).
24. 24. Legradi G, Emerson CH, RExfors SA et al. Neuroendocrinology 68, 89-97 (1998).
25. 25. Larsen PJ, Mikkelsen JD, Jessop D et al. J Endocrinol 141, 497-503(1994).
26. 26. Broberger C, Johansen J, Johansson C et al. Proc Natl Acad Sci USA 95, 15043-15048 (1998).
27. 27. Elias CF, Lee C, Kelly J et al. Neuron 21, 1375-1385 (1998).
28. 28. Bai JM, Yamano M, Shiotani Y et al. Brain Res 331, 172-175 (1985).
29. 29. Kesterson RA, Huszar D, Lynch CA et al. Mol Endocrinol 11, 630-637 (1997).